178 filings
Page 3 of 9
CORRESP
RNAZ
TransCode Therapeutics Inc
25 Sep 23
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
25 Sep 23
Correspondence with SEC
12:00am
S-1/A
RNAZ
TransCode Therapeutics Inc
IPO registration (amended)
22 Sep 23
9:56pm
CORRESP
RNAZ
TransCode Therapeutics Inc
22 Sep 23
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
22 Sep 23
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
22 Sep 23
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
15 Sep 23
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
15 Sep 23
Correspondence with SEC
12:00am
S-1/A
RNAZ
TransCode Therapeutics Inc
IPO registration (amended)
8 Sep 23
9:54pm
UPLOAD
RNAZ
TransCode Therapeutics Inc
31 Aug 23
Letter from SEC
12:00am
S-1
RNAZ
TransCode Therapeutics Inc
IPO registration
29 Aug 23
4:10pm
8-K
RNAZ
TransCode Therapeutics Inc
24 Aug 23
TransCode Therapeutics Announces First Subject Dosed with Radiolabeled TTX-MC138 in First-In-Human Clinical Trial
4:05pm
10-Q
2023 Q2
RNAZ
TransCode Therapeutics Inc
Quarterly report
14 Aug 23
4:31pm
8-K
RNAZ
TransCode Therapeutics Inc
4 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
RNAZ
TransCode Therapeutics Inc
28 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
4
RNAZ
TransCode Therapeutics Inc
22 Jun 23
Transcode Therapeutics / Robert Michael Dudley ownership change
6:23pm
SC 13D/A
Robert Michael Dudley
16 Jun 23
Transcode Therapeutics / Dudley Robert Michael ownership change
4:00pm
4/A
RNAZ
TransCode Therapeutics Inc
14 Jun 23
Transcode Therapeutics / Robert Michael Dudley ownership change
4:16pm
4
Robert Michael Dudley
13 Jun 23
Transcode Therapeutics / Robert Michael Dudley ownership change
4:16pm
8-K
RNAZ
TransCode Therapeutics Inc
8 Jun 23
TransCode Therapeutics Announces Pricing of $7 Million Public Offering
5:25pm